Research & Innovation Information Centre
Tick (check) box to add article to PDF "basket"
Cardiovascular diseases (CVD) are a major cause of morbidity and mortality in Europe. Prevention relies on measuring traditional risk factors such as age, gender, hypertension, diabetes, hypercholesterolemia and smoking. However, many individuals, apparently at low-risk, still develop CVD. Improving predictions beyond the traditional risk factors is the challenge undertaken by Prof. Olle Melander with his EU funded research project - CARDIOPREVENT.
Published: 8 August 2016
Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.
Published: 20 July 2016
European researchers have designed brain-like artificial neural networks capable of numerical and spatial cognition and written language processing without any explicit training or pre-programming. Their work, based on the machine-learning approach of generative models, significantly advances the development of self-learning artificial intelligence, while also deepening understanding of human cognition.
Published: 18 July 2016
The EU is investing in research to help European manufacturers remain competitive in a growing market for personalised medical products. Two projects are developing ways to use 3D printing to make tailor-made components for the benefit of patients.
Published: 13 June 2016
Developing new anti-cancer treatments is expensive, and national, public funding organisations across Europe dedicate substantial resources to this task. Linking their research programmes helps to ensure these funds are used to best effect. Transcan is now continuing as the Transcan-2 network, fostering long-term transnational synergy.
Published: 8 June 2016
A promising stem cell treatment for diabetic kidney disease will be assessed in a clinical trial run by the EU-funded project NEPHSTROM. The trial is one of a series of steps to determine whether the treatment is effective and safe for patients with this life-threatening condition.
Published: 31 May 2016
A breakthrough in prosthetics technology by EU-funded researchers will provide amputees with clinically and commercially viable artificial limbs offering intuitive, proportional and simultaneous control of hand, wrist and elbow movements in the near future.
Published: 27 May 2016
As people age, the more likely they are to be reaching for their reading glasses due to failing near sight or presbyopia. But thanks to EU research, contact lenses providing correct vision at all distances could be on the horizon.
Published: 25 May 2016
EU-funded project PRISAR is developing a hybrid probe that doctors can use to more precisely target cancerous tumours in image-guided surgery and during post-operative radiotherapy treatment. The project aims to improve treatments for cancer patients and save more lives.
Published: 11 May 2016
Pancreatic cancer is usually detected too late, leaving patients little hope of recovery. But this may be about to change. A Swedish SME has developed a blood test to help clinicians identify new cases earlier, and it intends to make this diagnostic capability available very soon. Clinical validation is under way in an EU-funded project.
Published: 22 April 2016